OR WAIT null SECS
September 26, 2017
UPS has revealed a new system to improve drug supply chain security, in compliance with the Drug Supply Chain Security Act (DSCSA).
September 25, 2017
FDA participated in a global operation to combat the sale and distribution of unapproved and illegal drugs.
September 21, 2017
The agency sent out 13 warning letters on Sept. 19, 2017 to companies selling drug products online.
September 11, 2017
FDA cited Meridian Medical Technologies, a Pfizer company, which manufactures Mylan’s EpiPen, for cGMP violations that included failure to appropriately investigate defects in auto-injector components.
September 07, 2017
The Portable, Continuous, Miniature, and Modular (PCMM) collaboration is alive and well, and the second generation of its modular continuous manufacturing equipment is now available.
September 02, 2017
It’s time to stop talking about “anticounterfeiting,” and move to integrated, collaborative supply chain security, experts say.
Emerging anticounterfeiting technologies offer pharmaceutical manufacturers more options for supply chain security.
August 18, 2017
The agency published guidance on identifying trading partners under DSCSA.
August 16, 2017
Pilot tests will evaluate a system developed by Ambrosus Technologies, using smart contracts and advanced sensors to ensure pharmaceutical quality, safety, and traceability.
August 10, 2017
Artificial intelligence offers a number of opportunities in pharmaceutical drug development and manufacturing, but there are barriers to overcome, notably around how well and how quickly the regulatory environment can adapt and keep pace with to the rapid changes.